Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term drug. Found 16 abstracts

Canter D, Simhan J, Smaldone MC, Lebed B, Tokar JL, Wu KN, Uzzo RG, Gustafson KS, Patchefsky AS, Plimack ER, Hoffman JP, Kutikov A. Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas. Urology. 2012 Feb;79(2):e9-10.   PMCID: not NIH funded
Gradilone A, Naso G, Raimondi C, Cortesi E, Gandini O, Vincenzi B, Saltarelli R, Chiapparino E, Spremberg F, Cristofanilli M, Frati L, Agliano AM, Gazzaniga P. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Annals of Oncology. 2011 Jan;22(1):86-92.   PMCID: not NIH funded
Schilder RJ, Blessing JA, Shahin MS, Miller DS, Tewari KS, Muller CY, Warshal DP, McMeekin S, Rotmensch J. A Phase 2 Evaluation of Irofulven as Second-line Treatment of Recurrent or Persistent Intermediately Platinum-Sensitive Ovarian or Primary Peritoneal Cancer A Gynecologic Oncology Group Trial. International Journal of Gynecological Cancer. 2010 Oct;20(7):1137-41.   PMCID: PMC3079178
Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T, Movsas B. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Phys. 2008 Dec;72(5):1378-84.
Small W, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20;26(6):942-7.
Huang CH, Treat J. New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors. Oncology. 2001 Jan;61 Suppl 1:14-24.
Movsas B. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer. Oncology (Huntingt). 2001 Dec;15(12):1549-58.
Steinberg G, Bahnson R, Brosman S, Middleton R, Wajsman Z, Wehle M. Efficacy and safety of valrubicin for the treatment of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. Journal of Urology. 2000 Mar;163(3):761-7.
Yin ZM, Ivanov VN, Habelhah H, Tew K, Ronai Z. Glutathione S-transferase p elicits protection against H2O2- induced cell death via coordinated regulation of stress kinases. Cancer Research. 2000 Aug;60(15):4053-7.
Socinski MA, Langer CJ. Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer. Seminars in Oncology. 1999 Oct;26(5):51-61.
Bookman MA, Malmstrom H, Bolis G, Gordon A, Lissoni A, Krebs JB, Fields SZ. Topotecan for the treatment of advanced epithelial ovarian cancer: An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel. Journal of Clinical Oncology. 1998 Oct;16(10):3345-52.
Dinh TQ, Du XH, Smith CD, Armstrong RW. Synthesis, conformational analysis, and evaluation of the multidrug resistance-reversing activity of the triamide and proline analogs of hapalosin. Journal of Organic Chemistry. 1997 Oct 03;62(20):6773-83.
Shen HX, Paul S, Breuninger LM, Ciaccio PJ, Laing NM, Helt M, Tew KD, Kruh GD. Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry. 1996 May 07;35(18):5719-25.
Lee Y, Emerson CP, Kim MH. A rapid and simple method for the isolation of mutant variants regulating tissue-specific expression of the TnI gene through drug selection. Applied Biochemistry and Biotechnology. 1995 Dec;55(3):231-40.
Arisawa Y, Sutantoward E, Dalton RR, Sigurdson ER. Short-Term Intrahepatic Fudr Infusion Combined with Bolus Mitomycin-C - Reduced Risk for Developing Drug-Resistance. Journal of surgical oncology. 1994 Jun;56(2):75-80.
Smith CD, Mooberry SL, Zhang XQ, Helt AM. A Sensitive Assay for Taxol and Other Microtubule-Stabilizing Agents. Cancer letters. 1994 May 16;79(2):213-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term drug

drug therapy cancer Treatment Outcome Neoplasm Staging pathology Female Lung Neoplasms drug therapy surgery therapeutic use carcinoma Non-Small-Cell Lung Carcinoma administration & dosage radiotherapy Male Antineoplastic Combined Chemotherapy Protocols Adjuvant Radiotherapy Adjuvant Chemotherapy agents Human Aged combination gene expression invitro Combined Modality Therapy tumor infusion Pancreatic Neoplasms taxol Survival Analysis survival diagnosis progression in-situ randomized trial adverse induction physiopathology cyclic depsipeptide hepatic intraarterial floxuridine Randomized Controlled Trials mammalian-cells instillation Urinary Bladder Neoplasms psychology stage-iii organoboranes adverse effects analogs & 3-hour infusion selection effects marker Antineoplastic Antimetabolites pathways Prognosis fluorodeoxyuridine uptake apoptosis accumulation derivatives arterial Neutropenia hydroxy functions hl-60 cells activated protein-kinase colorectal-cancer apoptosis induction immunology ifosfamide agent hapalosin hepatic metastases tubulin convergent animal model radical cystectomy solid tumors mgi-114 profile bone-marrow myod1 previously untreated patients circulating tumor cells Sexual Behavior Topotecan enzymes Carboplatin Non-US Gov't Support fast troponin I gene Small Cell Carcinoma chemically induced Radiation-Protective Agents enzymology Quality of Life physiology Socioeconomic Factors stage-specific expression mutant platinum chemosensitivity Adult Pancreatic Cyst Deglutition Pancreatic Ducts fibroblasts hmaf liver canalicular membrane bladder ultrastructure vinblastine estrogen-receptor Middle Aged CA-19-9 Antigen blood Amifostine 80 and over Aged glycoprotein genomic rearrangement 6-hydroxymethylacylfulvene Transitional Cell Carcinoma lines Clinical Trials inhibitor GOG neoplasms mortality Weight Loss Platinum-sensitive ovarian cancer mpm 4-methoxybenzyl myoblast resistant cells molecular mechanics breast cancer colorectal cancer Irofulven chemotherapy resistance transitional-cell carcinoma differentiation chiral synthesis Conformal Radiotherapy vesicles Biological Tumor Markers liver metastases long secondary Lymphatic Metastasis Hematuria cancer stem cells
Last updated on Friday, January 03, 2020